Crossref
A narrative review on palbociclib for hormone receptor-positive and human epidermal growth factor receptor-2 negative advanced breast cancer
Cancer Advances · 2022
DOI: 10.53388/2022522011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Advances, 2022. Verfasst von AnShun Zhang und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, A., Yin, J., & Song, C. (2022). A narrative review on palbociclib for hormone receptor-positive and human epidermal growth factor receptor-2 negative advanced breast cancer. Cancer Advances. https://doi.org/10.53388/2022522011
Vancouver
Zhang A, Yin J, Song C. A narrative review on palbociclib for hormone receptor-positive and human epidermal growth factor receptor-2 negative advanced breast cancer. Cancer Advances. 2022. doi:10.53388/2022522011
BibTeX
@article{Zhang2022,
author = {Zhang, AnShun and Yin, JiangXia and Song, ChangMing},
title = {A narrative review on palbociclib for hormone receptor-positive and human epidermal growth factor receptor-2 negative advanced breast cancer},
journal = {Cancer Advances},
year = {2022},
doi = {10.53388/2022522011}
}
EUVIMED